Research progress of mitochondrial dysfunction in drug-induced liver injury

Drug-induced liver injury (DILI) is a type of drug-induced liver injury with complex and diverse mechanisms that can lead to liver failure in severe cases, thereby affecting patients' quality of life and survival. In recent years, mitochondrial dysfunction has been shown to play a key role in the occurrence and development of DILI. As the center of cellular energy metabolism, impaired mitochondrial function not only leads to energy deficiency in hepatocytes but also may trigger a series of chain reactions, such as oxidative stress and hepatocyte death. Although several studies have revealed different mechanisms of mitochondrial damage and their associations with DILI, there is still a lack of systematic elucidation of the specific mechanisms and influencing factors. Therefore, this article aims to comprehensively review the latest research progress on mitochondrial dysfunction in DILI, with a particular emphasis on the mechanisms and influencing factors of mitochondrial damage. By analyzing existing literature, it is hope to provide valuable insights and guidance for the clinical intervention and treatment of DILI.